ImmunityBio, Inc.

IBRX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$0$138$61$143
Short-Term Investments$0$16$1$6
Receivables$0$22$17$3
Inventory$0$7$8$8
Other Curr. Assets-$154$26$22$24
Total Curr. Assets$0$208$109$185
Property Plant & Equip (Net)$0$168$167$170
Goodwill$0$1$1$0
Intangibles$0$14$15$16
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$11$12$12
Total NC Assets$0$194$195$198
Other Assets$0$0$0$0
Total Assets$0$402$304$383
Liabilities
Payables$0$7$14$7
Short-Term Debt$0$7$7$7
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$0$36$28$41
Total Curr. Liab.$0$51$49$55
LT Debt$0$528$519$497
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$570$393$326$319
Total NC Liab.$570$921$845$816
Other Liabilities$0$0$0$0
Cap. Leases$0$43$41$42
Total Liabilities$570$972$894$871
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings$0-$3,597-$3,505-$3,375
AOCI-$571$13$20$1
Other Equity$1$3,014$2,893$2,885
Total Equity-$570-$571-$591-$489
Supplemental Information
Minority Interest$0$1$1$1
Total Liab. & Tot. Equity$0$402$304$383
Net Debt$0$398$466$361